Compounds > atropine
Page last updated: 2024-09-05

atropine and 1-(4-methoxybenzyl)-5-(trifluoromethoxy)indoline-2,3-dione

atropine has been researched along with 1-(4-methoxybenzyl)-5-(trifluoromethoxy)indoline-2,3-dione in 1 studies

Compound Research Comparison

Studies
(atropine)		Trials
(atropine)		Recent Studies (post-2010)
(atropine)		Studies
(1-(4-methoxybenzyl)-5-(trifluoromethoxy)indoline-2,3-dione)		Trials
(1-(4-methoxybenzyl)-5-(trifluoromethoxy)indoline-2,3-dione)		Recent Studies (post-2010) (1-(4-methoxybenzyl)-5-(trifluoromethoxy)indoline-2,3-dione)
26,7111,2591,697604

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bridges, TM; Conn, PJ; Gentry, PR; Jadhav, SB; Jones, CK; Lindsley, CW; Marlo, JE; Niswender, CM; Plumley, HC; Weaver, CD1

Other Studies

1 other study(ies) available for atropine and 1-(4-methoxybenzyl)-5-(trifluoromethoxy)indoline-2,3-dione

ArticleYear
Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.
    Journal of medicinal chemistry, 2009, Jun-11, Volume: 52, Issue:11

    Topics: Allosteric Regulation; Animals; CHO Cells; Cricetinae; Cricetulus; Isatin; Mice; Receptor, Muscarinic M5

2009